Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload

Circ Heart Fail. 2014 Mar 1;7(2):340-50. doi: 10.1161/CIRCHEARTFAILURE.113.000984. Epub 2014 Jan 6.

Abstract

Background: Although matrix metalloproteinases (MMPs) were initially thought to result primarily in extracellular matrix degradation, certain MMP types, such as membrane type-1 (MT1) MMP, may also be involved in profibrotic cascades through hydrolysis of latency-associated transforming growth factor-binding protein (LTBP-1) and activation of transforming growth factor-dependent profibrotic signaling. The present study tested the hypothesis that MT1-MMP plays a direct role in the matrix remodeling response to a left ventricular (LV) pressure overload (PO) stimulus.

Methods and results: Wild-type (WT) and transgenic mice with cardiac-restricted MT1-MMP overexpression or MT1-MMP reduced expression underwent PO for 4 weeks. PO resulted in a 57% increase in LV mass (no change in LV end diastolic volume, resulting in an increase in the LV mass/volume ratio consistent with concentric remodeling), a 60% increase in MT1-MMP-mediated LTBP-1 hydrolysis and a 190% increase in collagen content in WT mice. Although LV mass was similar among WT, MT1-MMP overexpression, and MT1-MMP reduced expression after PO, significant differences in LV function, MT1-MMP-mediated LTBP-1 hydrolysis, and collagen content occurred. PO in MT1-MMP overexpression increased LTBP-1 hydrolysis (18%), collagen content (60%), and left atrial dimension (19%; indicative of LV diastolic dysfunction) when compared with WT. PO in MT1-MMP reduced expression reduced left atrial dimension (19%), LTBP-1 hydrolysis (40%), and collagen content (32%) when compared with both WT.

Conclusions: Despite an equivalent PO stimulus and magnitude of LV myocardial growth, altering MT1-MMP levels caused specific matrix-dependent changes in remodeling, thereby demonstrating a mechanistic role in the development of the maladaptive remodeling and myocardial fibrotic response to PO.

Keywords: hypertrophy; left ventricular; matrix metalloproteinases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Echocardiography
  • Gene Expression Regulation*
  • Hypertrophy, Left Ventricular / diagnosis
  • Hypertrophy, Left Ventricular / genetics*
  • Hypertrophy, Left Ventricular / physiopathology
  • Immunoblotting
  • Matrix Metalloproteinase 14 / biosynthesis
  • Matrix Metalloproteinase 14 / genetics*
  • Mice
  • Mice, Transgenic
  • Myocardium / enzymology*
  • Myocardium / pathology
  • RNA / genetics*
  • Real-Time Polymerase Chain Reaction
  • Ventricular Pressure / physiology*
  • Ventricular Remodeling / physiology*

Substances

  • RNA
  • Matrix Metalloproteinase 14